Charité - Universitätsmedizin Berlin

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry. (2021) Thaler FS, Zimmermann L, Kammermeier S, Strippel C, Ringelstein M, Kraft A, Suhs KW, et al. Journal article Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study. (2021) Nickenig G, Friedrichs KP, Baldus S, Arnold M, Seidler T, Hakmi S, Linke A, et al. Journal article Membrane Transporters and Channels in Melanoma (2021) Böhme-Schäfer I, Schoenherr R, Eberle J, Boßerhoff AK Journal article, Review article Effects Of Immune Cells On Mesenchymal Stem Cells During Fracture Healing (2021) Ehnert S, Relja B, Schmidt-Bleek K, Fischer V, Ignatius A, Linnemann C, Rinderknecht H, et al. Journal article Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) Cossarizza A, Chang HD, Radbruch A, Abrignani S, Addo R, Akdis M, Andrä I, et al. Journal article Patient preferences for treatment of advanced melanoma: impact of comorbidities (2021) Weilandt J, Diehl K, Schaarschmidt ML, Kiecker F, Sasama B, Pronk M, Ohletz J, et al. Journal article Patientenpräferenzen für die Therapie fortgeschrittener Melanome: Einfluss von Komorbidität (2021) Weilandt J, Diehl K, Schaarschmidt ML, Kiecker F, Sasama B, Pronk M, Ohletz J, et al. Journal article Adjuvant radiotherapy and local recurrence in vulvar cancer – a subset analysis of the AGO-CaRE-1 study (2021) Woelber L, Prieske K, Eulenburg Cz, Corradini S, Petersen C, Bommert M, Blankenstein T, et al. Journal article IJCARS: BVM 2021 special issue (2021) Maier A, Deserno TM, Handels H, Maier-Hein K, Palm C, Tolxdorff T Journal article Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer (2021) Schneeweiss A, Michel LL, Möbus V, Tesch H, Klare P, Hahnen E, Denkert C, et al. Journal article